scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2018.05.019 |
P698 | PubMed publication ID | 29778519 |
P50 | author | Bo T. Hansen | Q47368348 |
Maria Hortlund | Q57021947 | ||
P2093 | author name string | Susanne K Kjaer | |
Joakim Dillner | |||
Mari Nygård | |||
Christian Munk | |||
Kai-Li Liaw | |||
Camilla Lagheden | |||
P2860 | cites work | Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study | Q38599579 |
Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. | Q39281387 | ||
Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program | Q42220415 | ||
Modelling patterns of clearance of HPV-16 infection and vaccination efficacy | Q43946877 | ||
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes | Q69899836 | ||
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience | Q26745696 | ||
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis | Q28084924 | ||
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study | Q28245583 | ||
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia | Q28296557 | ||
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women | Q30052389 | ||
Human papillomavirus vaccination: the population impact | Q33806566 | ||
Role of herd immunity in determining the effect of vaccines against sexually transmitted disease | Q34380787 | ||
Cervical cancer: prevention, diagnosis, and therapeutics | Q34385040 | ||
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. | Q36734952 | ||
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination | Q37078556 | ||
Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study | Q37839810 | ||
Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study | Q37843055 | ||
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years | Q38383530 | ||
Registry-based assessment of the status of cervical screening in Sweden | Q38408579 | ||
P433 | issue | 26 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 10 | |
P304 | page(s) | 3820-3829 | |
P577 | publication date | 2018-05-31 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs | |
P478 | volume | 36 |
Q90629815 | An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway |
Q98175047 | Authors' reply |
Q97565439 | Evidence of HPV vaccination efficacy comes from more than clinical trials |
Q61805846 | Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study |
Q90098604 | Letter to the editor |
Q78879005 | Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis |